# A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants

> **NCT07460284** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Guangdong Raynovent Biotech Co., Ltd** · enrollment: 8 (estimated)

## Conditions studied

- Basic Science

## Interventions

- **DRUG:** 14C-RAY1225

## Key facts

- **NCT ID:** NCT07460284
- **Lead sponsor:** Guangdong Raynovent Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-15
- **Primary completion:** 2026-10-14
- **Final completion:** 2026-10-28
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07460284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07460284, "A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07460284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*